Stem Cell Treatment for Alzheimer's


Stem Cell Treatment for Alzheimer's

Alzheimer's disease is characterized by the accumulation of abnormal protein deposits in the brain, specifically beta-amyloid plaques and tau tangles. These abnormal protein deposits lead to the death of nerve cells in the brain, causing a gradual decline in cognitive abilities and memory.

Common symptoms of Alzheimer's disease include:

1.  Memory loss: Initially, short-term memory loss may occur, but as the disease progresses, long-term memory is also affected.

2.  Difficulty with language: Individuals may have trouble finding the right words, following conversations, or understanding written or spoken language.

3.  Disorientation and confusion: People with Alzheimer's may get lost in familiar places and have difficulty recognizing faces and objects.

4.  Impaired judgment and decision-making: This can lead to poor financial choices or difficulty with problem-solving.

5.  Changes in mood and behavior: Alzheimer's patients may experience mood swings, depression, anxiety, and withdrawal from social activities.

As Alzheimer's disease advances, individuals may require increasing levels of assistance with daily tasks and personal care. The progression of the disease varies from person to person, but it typically leads to severe cognitive and functional impairment.

Alzheimer's disease, but some medications and treatments may help manage symptoms and slow its progression in some cases. Research continues to explore potential treatments and preventive measures for Alzheimer's disease.

What may this include:

•Medical Consultation

•150 million MSCs

•Exosomes 500 MC (amount is determined by our doctors depending on age/weight ).

•Post therapy diet


1.Tfilin M, Sudmant PH, Joseph-Strauss D, Sabag O, Gafni A, Benitez-King G, Lajmanovich A, Zisapel N. Human iPSC-Derived Neural Cells Reveal Human Synaptic Activity and Short-Term Plasticity. Stem Cell Reports. 2019 Mar 12;12(3):582-596. doi: 10.1016/j.stemcr.2019.01.015. Epub 2019 Feb 14. PMID: 30773399; PMCID: PMC6410552.

2.Espuny-Camacho I, Arranz AM, Fiers M, Snellinx A, Ando K, Munck S, Bonnefont J, Lambot L, Corthout N, Omodho L, Vanden Eynden E, Radaelli E, Tesseur I, Wray S, Ebneth A, Hardy J, Leroy K, Brion JP, Vanderhaeghen P, De Strooper B. Hallmarks of Alzheimer's Disease in Stem-Cell-Derived Human Neurons Transplanted into Mouse Brain. Neuron. 2017 Apr 19;93(5):1066-1081.e8. doi: 10.1016/j.neuron.2017.02.001. Epub 2017 Mar 9. PMID: 28285823; PMCID: PMC5409901.

Martínez-Morales PL, Revilla A, Ocaña I, González C, Sainz P, McGuire D, Liste I. Progress in Stem Cell-Based Therapies for Parkinson's Disease. Prog Neurobiol. 2017 Oct;156:69-88. doi: 10.1016/j.pneurobio.2017.05.007. Epub 2017 May 20. PMID: 28536070.